Clinical Trials
PF-08634404 monotherapy or in combination w/Enfortumab Vedotin in patients with urothelial cancer
Disease Type: Urothelial
An Interventional Phase 1b/2, Open-Label Study to Investigate the Safety, Antitumor Activity, and Pharmacokinetics of PF-08634404 Monotherapy or in Combination With Enfortumab Vedotin in Adult Participants With Locally Advanced or Metastatic Urothelial Cancer
Locations
Alleghany , Blacksburg , Roanoke , Salem , Wytheville